Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells by Aguiari, G et al.
 
Cell Prolif. 
 
2008, 
 
41
 
, 554
 
–
 
573 doi:10.1111/j.1365-2184.2008.00529.x
 
© 2008 The Authors
 
554
 
Journal compilation © 2008 Blackwell Publishing Ltd.
 
Blackwell Publishing Ltd Oxford, UK CPR Cell Proliferation 0960-7722 1365-2184 © 2008 The Authors Journal compilation © 2008 Blackwell Publishing Ltd XXX  
 
ORIGINAL ARTICLES
 
Polycystin-1, Ca
 
2+
 
 waves and cell growth G. Aguiari
 
 et al.
 
Novel role for polycystin-1 in modulating cell proliferation 
through calcium oscillations in kidney cells
 
G. Aguiari*, V. Trimi*, M. Bogo*, A. Mangolini*, G. Szabadkai†, 
P. Pinton†, R. Witzgall§, P. C. Harris¶, P. A. Borea‡, R. Rizzuto† and 
L. del Senno*
 
*
 
Department of Biochemistry and Molecular Biology; 
 
†
 
General Pathology, Department of Experimental and Diagnostic 
Medicine; 
 
‡
 
Pharmacology Unit, Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, 
Italy, 
 
§
 
Institute for Molecular and Cellular Anatomy, University of Regensburg, Regensburg, Germany, and 
 
¶
 
Division 
of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, MN, USA
Received 
 
17
 
 July 
 
2007
 
; revision accepted 
 
18
 
 October 
 
2007
 
Abstract.
 
Objectives
 
: Polycystin-1 (PC1), a signalling receptor regulating Ca
 
2+
 
-
permeable cation channels, is mutated in autosomal dominant polycystic kidney dis-
ease, which is typically characterized by increased cell proliferation. However, the
precise mechanisms by which PC1 functions on Ca
 
2+
 
 homeostasis, signalling and cell
proliferation remain unclear. Here, we investigated the possible role of PC1 as a mod-
ulator of non-capacitative Ca
 
2+
 
 entry (NCCE) and Ca
 
2+
 
 oscillations, with downstream
effects on cell proliferation. 
 
Results and discussion
 
: By employing RNA interference,
we show that depletion of endogenous PC1 in HEK293 cells leads to an increase in
serum-induced Ca
 
2+
 
 oscillations, triggering nuclear factor of activated T cell activation
and leading to cell cycle progression. Consistently, Ca
 
2+
 
 oscillations and cell prolifer-
ation are increased in PC1-mutated kidney cystic cell lines, but both abnormal features
are reduced in cells that exogenously express PC1. Notably, blockers of the NCCE
pathway, but not of the CCE, blunt abnormal oscillation and cell proliferation. Our
study therefore provides the ﬁrst demonstration that PC1 modulates Ca
 
2+
 
 oscillations
and a molecular mechanism to explain the association between abnormal Ca
 
2+
 
 home-
ostasis and cell proliferation in autosomal dominant polycystic kidney disease.
INTRODUCTION
 
Increases in cytosolic concentration of Ca
 
2+
 
 ions [Ca
 
2+
 
]
 
i
 
 regulate virtually all cellular processes,
including events such as survival, proliferation and apoptosis, which decide the fate of each cell
(Berridge 
 
et
 
 
 
al
 
. 2000). These functions are disturbed in autosomal dominant polycystic kidney
disease (ADPKD), one of the most common inherited diseases in humans (1 in 500 to 1 in
1000), and one that accounts for about 10% of end-stage renal failure. The primary phenotype
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of ADPKD is the progressive expansion, in both kidneys, of multiple ﬂuid-ﬁlled cysts, which
gradually replace normal renal tissue and lead to end-stage renal failure and dialysis dependency
by mid-to-late adulthood (Gabow
 
 1
 
990). The systemic nature of the disease is determined by a
number of extrarenal manifestations (from hepatic and brain cysts to heart valve and cerebrovascular
abnormalities) that accompany the kidney cysts (Gabow
 
 1
 
990) and indicate the complex role of
ADPKD causative gene products (Ong & Harris
 
 2
 
005).
In approximately 85% of ADPKD cases, the disease arises as a consequence of loss of
function and missense mutations of the 
 
PKD1
 
 gene, which encodes polycystin-1 (PC1), with the
remaining cases being caused by mutations in polycystin-2-encoding 
 
PKD2
 
 gene (PC2) (Mochizuki
 
et
 
 
 
al
 
. 1996; Harris
 
 1
 
999). The phenotypes associated with either genotype are otherwise very
similar, indicating that the two proteins function with the same pathways. PC1 and PC2 are the
prototype members of a new family of integral membrane proteins that play important roles in
a variety of biological processes, including fertilization, ion translocation and mechanotransduction
(Delmas
 
 2
 
004). PC1 (around 450 kDa and 11 transmembrane domains) acts as an orphan receptor
mainly involved in control of epithelial cell population growth (Bhunia 
 
et
 
 
 
al
 
. 2002; Kim 
 
et
 
 
 
al
 
.
2004; Li 
 
et
 
 
 
al
 
. 2005; Manzati 
 
et
 
 
 
al
 
. 2005), migration (Nickel 
 
et
 
 
 
al
 
. 2002; Polgar 
 
et
 
 
 
al
 
. 2005),
differentiation (Aguiari 
 
et
 
 
 
al
 
. 1998; Puri 
 
et
 
 
 
al
 
. 2004) and apoptosis (Boca 
 
et
 
 
 
al
 
. 2006). In association
with PC2, a Ca
 
2+
 
-regulated Ca
 
2+
 
-permeable non-selective cation channel (Hanaoka 
 
et
 
 
 
al
 
. 2000;
González-Perrett 
 
et
 
 
 
al
 
. 2001; Koulen 
 
et
 
 
 
al
 
. 2002), PC1 is required for regulation of the cell cycle
(Bhunia 
 
et
 
 
 
al
 
. 2002) and activation of cation permeable currents (Vandorpe 
 
et
 
 
 
al
 
. 2001; Babich
 
et
 
 
 
al
 
. 2004; Pelucchi 
 
et
 
 
 
al
 
. 2006); it is also thought to be involved in regulation of G-protein
signalling (Parnell 
 
et
 
 
 
al
 
. 1998; Delmas 
 
et
 
 
 
al
 
. 2002).
Our group has recently found that expression of a membrane-targeted PC1 C-terminus in
kidney HEK293 cells increases cell response to ATP-evoked [Ca
 
2+
 
]
 
i
 
 (Aguiari 
 
et
 
 
 
al
 
. 2003) and
serum-evoked cell proliferation (Manzati 
 
et
 
 
 
al
 
. 2005). It has also recently been reported that the
treatment of PKD-cystic cells with molecules causing sustained increases in [Ca
 
2+
 
]
 
i
 
 may reverse
their mitogenic response (Yamaguchi 
 
et
 
 
 
al
 
. 2006). Therefore, the aim of the present work was
to determine the mechanism by which PC1 modulates Ca
 
2+
 
 levels, considering the possibility
that a reduction in endogenous PC1 by small-interference RNA might affect Ca
 
2+
 
 mobilization
and thus induce a growth-stimulated phenotype characteristic of PKD cells. Our results,
obtained by employing pharmacological tools on kidney cell lines depleted of endogenous PC1
by PKD1 RNA interference or in PKD1 mutated cystic cell lines, demonstrate that down-
regulation of PC1 leads to elevation in Ca
 
2+
 
 oscillations by stimulating non-capacitative Ca
 
2+
 
entry (NCCE). Such oscillatory signals trigger nuclear factor of activated T cell (NFAT) activation
and other Ca
 
2+
 
-dependent signalling pathways, leading to increased cell proliferation. Furthermore,
the inhibitory effects of exogenously expressed PC1 on Ca
 
2+
 
 oscillations, as well as proliferation
of HEK293 cells, indicate PC1 as a physiological modulator of NCCE, which plays a crucial
role on basal and evoked [Ca
 
2+
 
]
 
i
 
 levels. These ﬁndings pave the way to future investigations on
involvement of such channels in both the physiology and pathophysiology of kidney cells.
 
MATERIALS AND METHODS
 
Reagents
 
Dulbeccos’s modiﬁed Eagle’s medium/F12 and minimum essential medium media, G418 antibiotic,
bovine serum albumin (BSA), 1-(beta-[3-(4-methoxyphenyl) propoxy]-4-methoxyphenethyl)-
1H-imidazole hydrochloride (SKF96365), cyclosporin A, gadolinium and anti-FLAG M2 mouse 
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monoclonal antibody were obtained from Sigma-Aldrich (Milano, Italy), foetal bovine serum
(FBS) was obtained from Eurobio (Celbio, Milan, Italy) and selective cell-permeable inhibitors
of protein kinase C (PKC)-α and PKC-β1 (Ro-320432 and hispidin, respectively), were
purchased from Calbiochem (La Jolla, CA, USA) and protease inhibitors were from Roche
Diagnostics (Monza, Italy). Rabbit polyclonal antitubulin and antirabbit rhodamine- and FITC-
conjugated antibody were obtained from Santa Cruz (DBA Italia Srl, Segrate, Italy), while rabbit
polyclonal antip27 antibody was obtained from Cell Signalling Technology (Celbio SRL, Italy).
Enhanced chemiluminescent substrates for Western blotting (SuperSignalDura or SuperSignalFemto)
and horseradish peroxidase-conjugated goat antirabbit and antimouse antibodies were purchased
from Pierce (Celbio S.r.l., Milan, Italy). The pSUPER RNAi System was obtained from
OligoEngene (Seattle, WA, USA). (R,S)-(3,4-dihydro-6,7-dimethoxy-isochinolin-1-yl)-2-
phenyl-N,N-di[2-(2,3,4trimethoxyphenyl)ethyl] acetamid mesylate (LOE908) was kindly provided
by Boehringer Ingelheim (Ingelheim, Germany).
Production of siRNA expressing vectors
Two siRNAs (a and b) for PC1 were constructed according to a published method (Brummelkamp
et al. 2002). Brieﬂy, 64 nt primers were designed to include a 19-nt PKD1 sequence, its complement,
a spacer region, 5′ BglII site and 3′ HindIII site.
The forward PKD1a primer sequence: 5′-GATCCCCCGACAAGCAGTCCCTGACCTTC-
AAGAGAGGTCAGGGACTGCTTGTCGTTTTAAA-3′ and the reverse primer sequence:
5′-AGCTTTTCCAAAAACGACAAGCAGTCCCTGACCTCTCTTGAAGGTCAGGGACTG-
CTTGTCGGGG-3′.
The forward PKD1b primer sequence: 5′-GATCCCCCTTCACGCGGAGCGGCACGT-
TCAAGAGACGTGCCGCTCCGCGTGAAGTTTTTGGAAA-3′ and the reverse primer
sequence: 5′-AGCTTTTCCAAAAACTTCACGCGGAGCGGCACGTCTCTTGAACGTGCC-
GCTCCGCGTGAAGGGG-3′. The target PKD1 sequence was substituted by a scramble nucleo-
tide sequence as control: 5′-TTCTCCGAACGTGTCACGT-3′. Annealed double strands of DNAs
were cloned into the pSUPER plasmid vector following the Oligoengene procedure.
Cells, stable transfection, cell cycle and proliferation assays
HEK293 cells were maintained and cultured as previously described (Manzati et al. 2005).
Wild-type (pSUPER) and recombinant constructs (pSiScramble, pSsiPKD1 a and b) were
co-transfected with pCDNA3 (ratio 1 : 10, respectively) by the calcium phosphate method,
in HEK293 cells (Pelucchi et al. 2006), and G418-resistant clones (HEK293pSUPER,
HEK293pSiScramble and HEK293pSsiPKD1), and were screened by Western blotting analysis,
through detection of endogenous PC1 protein using 7e12 monoclonal antibody (Qian et al.
2003). PKD1 RNA levels were analysed by real-time RT-PCR, as previously reported (Aguiari
et al. 2004). PKD1 RNA quantiﬁcation was obtained by the ΔCT method. Transcription of the
ACTIN housekeeping gene was used as endogenous RNA control for normalization and the
ΔCT was then calculated (ΔCT = CT(target gene) – CT(actin gene)). Final results, expressed as
Nfold content in PKD1 gene expression relative to the ACTIN gene, were determined as follows:
N(target) = 2–ΔΔCT, as previously described (Aguiari et al. 2004).
Cell cycle analysis was done with the use of ﬂow cytometry of propidium iodide-treated cells,
using the FACSCalibur Becton Dickinson Immunocytometry System. Previously described
SV40-transformed human cell lines (one derived from normal and two from cystic kidney cell
lines) (Nauli et al. 2006), were grown in Dulbeccos’s modiﬁed Eagle’s medium/F12, 10% FBS.
Cystic cells carry the Q2556X PKD1 mutation: one is heterozygous, while the other is
hemizygous, for deletion of the normal allele (Nauli et al. 2006). After plating at low densityPolycystin-1, Ca2+ waves and cell growth 557
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(30 000 cells/mL) in 24-well plates, cell proliferation was measured by direct cell counting
(Manzati et al. 2005), and by 24 and 48 h incubation with [3H] thymidine (1 μCi/mL).
Transient transfection and immunoﬂuorescence analysis
HEK293pSUPER and HEK293pSsiPKD1 cells were cultured on 24-mm coverslips for 24 h then were
transiently transfected with full-length FLAG-tagged mouse PC1 (Grimm et al. 2003) by Ca2+
phosphate precipitation. After 3 days of transfection, non-ﬁxed cells were washed twice with
phosphate-buffered saline (PBS) buffer and incubated at room temperature for 1 h with anti-
FLAG M2 mouse monoclonal antibody at a dilution of 1 : 200, in a solution containing 0.2%
gelatin. After three washes with PBS, cells were treated with a 0.2% gelatin PBS solution that
contained secondary antirabbit rhodamine-conjugated antibody at room temperature in the dark
for 1 h. After three washes in PBS, cells were analysed using a Zeiss Axiovert 200 ﬂuorescence
microscope equipped with a back-illuminated CCD camera (Roper Scientiﬁc, Tucson, AZ,
USA), excitation and emission ﬁlter wheels (Sutter Instrument Company, Novato, CA, USA), and
piezoelectric motoring of the Z stage (Physik Instrumente, GmbH and Co., Karlsruhe, Germany).
Ca2+ measurement
Measurements of FBS-evoked calcium levels were performed in cells grown on coverslips and
transfected with recombinant cytoplasmic aequorin cDNA (Aguiari et al. 2003). Seventy-
two hours after aequorin reconstitution, cells on coverslips were transferred into the perfusion
chamber of a luminometer and, following 1 min of perfusion, stimulated with 1% FBS. The
relationship between photon emission (L/Lmax) and Ca2+ concentration allows conversion by
computer algorithm of light released into the specimen. L and Lmax are the instant and maximal
rates of light emission, the former having been obtained after 1% FBS stimulation and the latter
brought about by cell lysis with 100 μm digitonin (Manzati et al. 2005).
Cytoplasmic Ca2+ oscillations were measured in Fura-2AM-loaded cells (Manzati et al.
2005). Cells, grown on coverslips, were starved ON with BSA, loaded with Fura-2AM (4 μm/
30 min/37 °C), and transferred to the thermostated stage of a Zeiss Axiovert 200 inverted microscope
equipped with a Sutter ﬁlterwheel and 340/380 excitation ﬁlters. Cells were stimulated either
with 1% FBS alone or with other molecules for 15 min or 30 min, acquiring 1 image every 1 s
or 3 s, respectively. Signals were computed into relative ratio units of the ﬂuorescence intensity
of different wavelengths (340/380 nm). Ca2+ oscillation amplitude was calculated by measuring
Ca2+ concentration in Fura-2AM-loaded cells, as previously described (Manzati et al. 2005).
Calibration was carried out using MetaFluor software, according to the equation [Ca2+] = Kd ×
(Sf2/Sb2) × (R–Rmin)/(Rmax–R), using Kd = 224 nm. Rmax and Rmin were determined at the end of
each experiment in KRB/Ca2+/1 μm ionomycin, and KRB/1 mm EGTA/ionomycin, respectively.
NFAT and PKC-α α α α ﬂuorescence analysis
Cells were transfected with either NFAT–green ﬂuorescent protein (GFP) or PKC-α-GFP
constructs by using the Ca2+ phosphate procedure (Manzati et al. 2005). NFAT and PKC-α
subcellular localization was analysed using a digital ﬂuorescence microscope, and images were
captured and recorded using a digital-imaging system (Manzati et al. 2005).
NFAT luciferase assay
After 24 h plating in a 6-well plastic plate, cells were transiently transfected with 4 μg of pNFAT-
TA-Luc plasmid DNA by the Ca2+ phosphate method, and 6  h post-transfection, they were
washed and incubated for an additional 20 h in medium supplemented with 1% FBS. After cell
treatment with passive lysis buffer (Promega, Madison, WI, USA), 25 μl of cell lysate was added558 G. Aguiari et al.
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to 50 μl of luciferase substrate (Promega) and then the samples were analysed using a 20/20n
luminometer (Turner Biosystems, Sunnyvale, CA, USA).
Statistical analysis
Where applicable, statistical errors of averaged data were given as means ± SD or SEM and
statistical signiﬁcance was assessed by Student’s t-test.
RESULTS
Relationship between PC1 depletion by RNA interference and proliferation of 
HEK293 cells
A variable, but consistent down-regulation of PC1 was accomplished in HEK293pSsiPKD1 cell
clones obtained by stable transfection with pSUPER plasmid expressing PKD1 siRNAs (Fig. 1a).
An average of more than ∼50% reduction in PC1 protein was found in clones transfected by
either the a or b PKD1 siRNA-cloned sequence, as compared to those transfected with the
empty vector or that expressing the scramble nucleotide sequence, as controls [Fig. 1b, PC1/β-
tubulin: 0.70 ± 0.09 and 0.55 ± 0.5 in HEK293pSsiPKD1 a and b clones (pSsiPKD1), respectively,
versus 1.52 ± 0.11 and 1.46 ± 0.34 in control HEK293pSUPER and HEK293pSiScramble clones (pS
and pSSc); P < 0.01 and P < 0.05, respectively, versus pS and P < 0.05 versus pSc]. This inhibition
of PC1 by siRNA was found to be selective as neither variations in β-tubulin were observed, nor
PC1 levels altered, in clones expressing the control vectors. Moreover, extent of PC1 inhibition
was consistent with the reduction in PKD1 RNA, as shown in HEK293pSsiPKD1 a cells by real-time
RT-PCR analysis (Fig. 1c).
Because the loss of PC1 in kidney cysts is associated with proliferation of epithelial cells,
and HEK293 cells overexpressing the putative dominant negative PC1 C-terminus have been
shown to increase cell proliferation (Manzati et al. 2005), HEK293pSsiPKD1 stably transfected
cells were assessed for possible changes in cell proliferation. PC1 inhibition did indeed cause a
signiﬁcant increase in 1% FBS-induced cell proliferation, as illustrated by the examples shown
in Fig. 1d. This increase was detectable both in [3H] thymidine uptake after 24 and 48 h incubation,
and after 3 and 5 days of culture (106 667 ± 5700 versus 62 333 ± 8500 and 65 100 ± 11 300
after 3 days of culture, and 203 333 ± 6500 versus 126 667 ± 5600 and 120 600 ± 17 800 after
5 days, respectively, in HEK293pSsiPKD1 cells versus HEK293pSUPER and HEK293pSiScramble con-
trol cells; P < 0.01 and P < 0.001 after 3 and 5 days, respectively). Furthermore, proliferation
increase in HEKpSsiPKD1 a1 and a3 cells was found to be smaller than that observed in b3 cells,
which showed the lowest PC1 levels (Fig. 1e), thus indicating a relationship between degree of
PC1 suppression and cell proliferation.
PC1 expression reduces calcium oscillation
The effect of PC1 silencing on [Ca2+]i evoked by FBS, at 1% concentration used in cell prolif-
eration studies, was initially investigated in HEKpSsiPKD1 clone a1 through both aequorin and
Fura-2AM experiments.
After transfection with Ca2+-sensitive photoprotein aequorin, a slight, although non-signiﬁcant,
increase in serum-induced cytoplasmic Ca2+ peak was found in HEKpSsiPKD1 cells, as compared
to control cells (bars of Fig. 2a). Nevertheless, it is apparent from representative traces of Fig. 2a
that Ca2+ levels were more sustained and oscillating in HEKpSsiPKD1 cells. These differences were
conﬁrmed in single-cell Ca2+-imaging experiments (Fig.  2b). Representative traces fromPolycystin-1, Ca2+ waves and cell growth 559
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HEK293pSUPER and HEK293pSsiPKD1 cells revealed a pattern of changes in FBS-evoked Ca2+ levels
that was characterized by oscillation frequency that was consistently higher in HEK293pSsiPKD1
cells. The oscillation increase was observed in 81.5% of cells (n = 76). When the analysis was
performed in different HEKpSsiPKD1 clones, mean oscillation frequency increased ∼2-fold as
compared to control cells (9.78 versus 5.52 and 5.36 in HEK293pSsiPKD1 and HEKpSiScramble cells,
respectively, the mean values in a 15-min period, P < 0.01) (Fig. 2c), suggesting a relationship
between reduced PC1 expression and increased Ca2+ oscillation. Oscillation amplitude,
expressed as Ca2+ concentration, was not different in HEK293pSUPER and HEK293pSsiPKD1 cells
(98.05 ± 29.12 nm and 102.00 ± 20.89 nm in HEK293pSUPER and HEK293pSsiPKD1 cells, respectively,
Fig. 2d), lending further support to the hypothesized association between PC1 deﬁciency and
oscillation frequency. Because the difference in oscillation frequency at 10% FBS concentration
was markedly reduced (from about 2 in 1% FBS to about 1.4-fold in 10% FBS, Fig. 2e), further
experiments were performed in 1% FBS. Moreover, because no signiﬁcant differences were
Figure 1. PKD1 gene silencing increases cell proliferation in HEK293 cells. (a) Western blot analysis of PC1 from
plasma membranes of HEK293 cells stably transfected with plasmids expressing two PKD1-speciﬁc siRNA (pSsiPKD1
a and b) and one scramble RNA sequence (pSsiScramble, pSc), and transfected with the pSUPER empty vector (pS).
A representative entire blot of the control HEK293pSUPER clone 1 (pS), and HEK293pSsiPKD1 clone a1 (pSsiPKD1) is
included. The analysis of PC1 probed with the monoclonal antibody 7e12 (Qian et al. 2003) was related to β-tubulin.
The variations in β-tubulin levels were due to unequal protein loading. Two a and three b HEK293pSsiPKD1 clones are
shown. (b) The expression of either pSsiPKD1 a or b construct signiﬁcantly reduced PC1 production in comparison with
that of β-tubulin. Bars show the average relative PC1 expression (± SEM) in six controls (three HEK293pSUPER, pS,
white bar; and three HEK293pSsiScramble, pSc, grained bar), 10 HEK293pSsiPKD1 a and 3 HEK293pSsiPKD1 b clones (dark
and light grey bars) from three independent experiments (a and b versus pS, **P < 0.01 and *P < 0.05, respectively,
unpaired Student’s t-test). (c) Fold decrease in PKD1 mRNA levels in HEK293pSsiPKD1 clone a (grey bar) compared to
HEK293pSUPER cells (pS, white bar), as detected by real-time RT-PCR analysis. PKD1 RNA levels relative to those of
actin RNA were measured by ΔΔCt values that were calculated as described in the Methods section. Bars show the aver-
age (± SD) of four different experiments (**P < 0.01, unpaired Student’s t-test). (d) [3H] thymidine incorporation after
both 24 and 48 h incubation with 1% FBS was higher in HEK293pSsiPKD1 clone b3 (grey bar) than to HEK293pSUPER
control cells (white bar); moreover, HEK293pSsiPKD1 cell proliferation was also increased after 3 and 5 days of culture
in the presence of 1% FBS (HEK293pSUPER cells, white bars, HEK293pSsiScramble cells, grained bars, and HEK293pSsiPKD1
clone a2, grey bars, the only one studied after 5 days). The data shown are the mean (± SD) of at least two independent
experiments (*P < 0.05, **P < 0.01 and ***P < 0.001, unpaired Student’s t-test). (e) After 3 days, cell proliferation
increase was greater in HEK293pSsiPKD1 b3 clone showing lower PC1 expression (hatched bars).560 G. Aguiari et al.
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observed between HEK293pSUPER and HEK293pSiScramble cells, further experiments were mainly
performed using HEK293pSUPER cells.
Consistent with increase in proliferation observed in HEK293pSsiPKD1 cells, oscillation frequency
was higher in HEK293pSsiPKD1 clones with higher proliferation rates (Fig. 2f), strongly indicating
the relation between Ca2+ oscillation frequency and cell proliferation. The b3 clone, which exhibited
greatest oscillation and proliferation associated with the most pronounced PC1 down-regulation
(Fig. 1e), was used in the further experiments.
To test the hypothesis of a role for PC1 in regulating Ca2+ oscillatory patterns, the latter were
examined in HEK293pSsiPKD1 cells transiently transfected with a cDNA plasmid expressing
mouse full-length PC1-containing N-ter FLAG and C-ter HA tags (Grimm et al. 2003). Exogenous
expression of mouse PC1 (mPC1) was demonstrated by anti-FLAG immunoblotting in total
Figure 2. PKD1 gene silencing increases FBS-induced Ca2+ oscillation frequency in HEK293 cells. (a) Representative
cytoplasmic Ca2+ levels from control HEK293pSUPER 1 (pS, blue trace) and HEK293pSsiPKD1 a1 (red trace) cells. Ca2+
levels were measured in cells transfected with the Ca2+-binding photoprotein cytAEQ. Where indicated, cells were
challenged with 1% FBS. Bars represent the peak evoked by FBS stimulation (averages ± SEM, P = 0.057) in control
(blue) and HEK293pSsiPKD1 (red) clones. (b) FBS increased Ca2+ oscillation frequency in PKD1-speciﬁc siRNA expressing
cells. Representative Ca2+ signals from an individual control pS (blue trace) and HEK293pSsiPKD1 a1 cell (red trace)
loaded with Fura-2-AM and stimulated with 1% FBS. Average distribution of Ca2+ oscillation frequency (± SD, white
parts of the bars) from HEK293pSUPER 1 (n = 66 cells, four experiments) and HEK293pSsiPKD1 a1 cells (61 = cells min
period, four experiments) in 15 min after FBS stimulation. (c) Bars indicate the average Ca2+ oscillation frequency in
four HEK293pSUPER, three HEK293pSsiScramble (black bar) and four HEK293pSsiPKD1 different clones. The data are the
means ± SEM of ﬁve experiments (P < 0.01 versus pS, unpaired Student’s t-test). (d) Average (± SD) of Ca2+ oscillation
amplitude in three HEK293pSUPER (blue bar) and ﬁve HEK293pSsiPKD1 (red bar) clones. Amplitude is expressed as Ca2+
concentration, measured as described in the Materials and Methods section. (e) Calcium oscillations (average ± SD)
evoked by treatment with 0%, 1% and 10% FBS in three HEK293pSUPER (blue bars) and four HEK293pSsiPKD1 (red bars)
clones. (f ) Cell proliferation increase as a function of Ca2+ oscillation frequency in four different HEK293pSsiPKD1 clones
relative to the HEK293pSUPER 1 control clone.Polycystin-1, Ca2+ waves and cell growth 561
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lysates of both HEK293pSUPER and HEK293pSsiPKD1 mPC1-transfected cells, and conﬁrmed in at
least 20% of cells by anti-FLAG immunoﬂuorescence (inset of Fig. 3), indicating that mPC1 was not
silenced by speciﬁc human PKD1 siRNA. mPC1 expression caused a clear reduction in oscillation
frequency in some cells (Fig. 3a), leading to an average 30% reduction (Fig. 3b, left). Notably,
a similar reduction was also observed in PC1-transfected HEK293pSUPER control cells (Fig. 3a,b,
right). Combined, these ﬁndings suggest that exogenous expression of PC1 is capable of reducing
Ca2+ oscillation in HEK293 kidney cells. Furthermore, stable transfection of mouse PC1 in
HEK293 cells caused a statistically signiﬁcant reduction in cell proliferation (Fig. 3c). After
Figure 3. Exogenous expression of PC1 reduces Ca2+ oscillation frequency in HEK293 cells. (a) Representative Ca2+
oscillation patterns from individual HEK293pSsiPKD1 (red) and HEK293pSUPER (blue) cells before (upper traces) and after
(lower traces) transient transfection with the mouse PC1 expressing plasmid (mPC1). Cells were grown on coverslips,
transfected with the plasmid DNA as described in the Materials and Methods section, loaded with Fura-2-AM after 48 h
and stimulated with 1% FBS, as described in Fig. 2. Inset: the expression of the mouse PC1 was conﬁrmed by Western
blotting and immunoﬂuorescence analysis, as shown in HEK293pSUPER (pS) and HEK293pSsiPKD1 (pSsiPKD1) trans-
fected cells, the latter showing that mPC1 is not silenced by human PKD1 siRNA. Cells were lysed and total extracts
were analysed by immunoblotting with the anti-FLAG M2 mouse monoclonal antibody recognizing the FLAG-tagged
mouse PC1, as described in the Materials and Methods section. The antibody identiﬁed a band of about 400 kDa in only
mPKD1 cDNA-transfected HEK293pSUPER and HEK293pSsiPKD1 cells. The ~200 kDa band was deemed to be aspeciﬁc
as present in all samples. For immunoﬂuorescence analysis, cells were ﬁxed and treated with M2 antibody, as described
in the Materials and Methods section. Upper and lower panels: contrast phase and ﬂuorescence images. Staining of
plasma membranes was indicated by arrows, mainly at cell–cell interactions. (b) Average percent reduction in Ca2+ oscil-
lation frequency in a 15-min period obtained after transient transfection with the mouse PC1 expressing plasmid of
HEK293pSsiPKD1 clone b3 (red bars; n = 122 cells, ﬁve experiments) and HEK293pSUPER cells (blue bars, n = 60, three
experiments). (c) Reduction in cell proliferation in HEK293 cells stably expressing the full length mouse PC1. pCDNA3
stably transfected control cells (white bar) and cells stably transfected with the full length mouse PKD1 cDNA plasmid
(grey bar) were grown for 3 days in presence of 1% FBS. Data are expressed as the average values (± SD; *P < 0.05
unpaired Student’s t-test) obtained from two control and four PC1-transfected clones that were plated as described in
the Materials and Methods section.562 G. Aguiari et al.
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3 days of 1% FBS treatment, mean cell proliferation was reduced almost by half in four different
PC1-transfected clones (371 833 ± 171 660 versus 766 666 ± 28 284 cells in transfected versus
untrasfected cells, respectively, P < 0.05). This ﬁnding demonstrates that PC1-dependent reduction
in Ca2+ oscillations is strongly associated to reduction in cell proliferation.
Calcium oscillation increases in human PC1-deﬁcient cystic cells
Enhancement of proliferation by PKD1 RNA interference suggests that HEK293pSsiPKD1 cells
behave in a similar fashion to ADPKD cyst cells, and an increase in cell proliferation and
frequency of Ca2+ oscillations in cells derived from PKD1 cysts was therefore expected. In order
to test this hypothesis immortalized cell lines from kidney cysts, which are heterozygous and
putatively hemizygous for the Q2556X PKD1 mutation (Nauli et al. 2006), were analysed and
results were compared to those obtained with PKD1 wild-type non-cystic cells.
After 1% FBS treatment for 24 h, cell cycle analysis showed that S and G2/M phases in
hemizygous and heterozygous PC1-mutant cystic cells were higher than in wild-type cells, thereby
demonstrating a higher proliferation rate of the cystic cells (Fig. 4a). Consistently in these cells,
FBS-evoked Ca2+ oscillations were increased (Fig. 4b). In particular, average oscillation frequency
over a 15-min period was 9.35 ± 1.36 and 7.36 ± 1.16 in cystic versus 3.904 ± 0.04 in normal
cells (P < 0.05, wild-type versus either hemizygous or heterozygous cells) (bars in Fig. 4b).
Figure 4. Immortalized cyst-lining cells derived from a human kidney with a PKD1 mutation have increased cell
proliferation and Ca2+ oscillations. (a) Cell cycle analysis in cystic cells, heterozygous (het) and hemizygous (hem)
for the Q2556X PKD1 mutation (Nauli et al. 2006) showed an increase in S and G2/M phases compared to normal kidney
cells (wt). After 24 h culture in 1% FBS, cells were analysed with propidium iodide staining as described in the Materials
and Methods section. (b) Kidney normal (wt) and cystic (het and hem) cells were plated on coverslips 1 day before Ca2+
imaging experiments, starved in BSA and loaded with Fura-2-AM as described in the Materials and Methods section.
During the experiment, cells were stimulated with 1% FBS and, after the initial Ca2+ transient, oscillations were
analysed. Representative Ca2+ oscillation patterns from individual cells are shown. The average oscillation frequency
(± SD) in 15 min is indicated by bars (wt, n = 56; het, n = 83; hem, n = 51 cells, in three experiments, *P < 0.05
unpaired Student’s t-test, wt versus hem and versus het).Polycystin-1, Ca2+ waves and cell growth 563
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Inhibitors of NCCE blunt both increased oscillation and cell proliferation
In order to ascertain the type of channel involved in the increase in FBS-evoked Ca2+ oscillations
in HEK293pSsiPKD1 clones, Ca2+ inﬂux was evaluated in the presence of inhibitors of CCE and NCCE
(Berridge 2002) (Fig. 5a). The frequency of FBS-evoked Ca2+ oscillations in HEK293pSsiPKD1
remained unaffected by the presence of 1 μm Gd3+, sufﬁcient to block CCE (Mignen et al.
2003a). However, oscillations were markedly affected by 5 μm Gd3+, which also completely
inhibits NCCE (Mignen et al. 2003a), in both HEK293pSsiPKD1 and HEK293pSUPER control cells.
Interestingly, treatment with 100 nm SKF96365, a putative inhibitor of receptor-operated Ca2+
entry with NCCE blocker activity at this low concentration (Moneer et al. 2003), provoked
markedly greater reduction in oscillation frequency in HEK293pSsiPKD1 more than in
HEK293pSUPER cells. In particular, treatment of HEK293pSUPER cells with either 1 μm Gd3+ or
100 nm SKF96365 caused a 38% or 50% reduction in Ca2+ oscillations, respectively; conversely,
Figure 5. NCCE-speciﬁc inhibitors blunt the effect of the PKD1 gene silencing or PKD1 nonsense mutation on
FBS-induced increase in Ca2+ oscillations. Effect of gadolinium (Gd3+) and SKF96365 on Ca2+ oscillation frequency.
Representative Ca2+ traces from individual HEK293pSUPER (blue lines) and HEK293pSsiPKD1 cells (red lines) loaded with
Fura-2-AM and treated with the indicated blocker and 1% FBS, are shown. The 1 μm Gd3+ did not affect Ca2+ oscilla-
tions activated by 1% FBS in HEK293pSsiPKD1 cells; 5 μm Gd3+ and 100 nm SKF96365 markedly reduced Ca2+ oscilla-
tions. Inset bars represent the average distribution of Ca2+ oscillation frequency (± SD) from HEK293pSUPER cells (1 μm
Gd3+: n = 45 cells; 5 μm Gd3+: n = 50 cells; 100 nm SKF96365: n = 52 cells) and from HEK293pSsiPKD1 cells (1 μm
Gd3+: n = 54 cells; 5 μm Gd3+: n = 42 cells; 100 nm SKF96365: n = 49 cells) in a 15-min period after FBS stimulation.
Results are representative of three independent experiments. Blue and red bars represent percentage reductions (± SD)
produced by each treatment in HEK293pSUPER (blue) and HEK293pSsiPKD1 cells (red) compared to untreated cells.564 G. Aguiari et al.
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in HEK293pSsiPKD1 cells, 1 μm Gd3+ did not affect Ca2+ oscillations, while SKF96365 caused an
82% reduction (see percentage values in Fig. 5). Ca2+ oscillations were also reduced by 2.5 times
in HEK293pSsiPKD1 (64%) than in HEK293pSUPER (25%) by treatment with 30 μm LOE908,
another NCCE blocker (Moneer & Taylor 2002) (data not shown), suggesting involvement of
NCCE activity in abnormal Ca2+ oscillations seen in PC1-deﬁcient cells.
Consistently with the results on Ca2+ oscillations, 5 μm Gd3+, but not 1 μm Gd3+, 100 nm
SKF96365 and 30  μm LOE908 markedly reduced the FBS-induced cell proliferation in
HEK293pSsiPKD1 clones (Fig. 6a). As shown in the summary graph of Fig. 6a (showing percentage
values), reductions in proliferation caused by different treatments highlighted the strong inhibition
caused by NCCE blockers in HEK293pSsiPKD1 cell proliferation (67% to 61%), in comparison to
the effect in control cells, which was observed to be four times lower (15%).
In order to conﬁrm inhibition also in cyst-derived cells, the effects of NCCE channel blockers
were examined in PKD1 Q2556X-mutated cell lines. As expected, cell proliferation was higher
in cystic cells than in wild-type cells (152  888.6  ±  18  151 and 130  553.3  ±  10  210 versus
105 777.5 ± 4337, in heterozygous and hemizygous versus wild-type cells, P < 0.05) (Fig. 6b).
Treatment with either 100 nm SKF96365 or 30 μm LOE908 NCCE blockers did not modify
proliferation of wild-type cells, although it did reduce that of PKD1 heterozygous and hemizygous
cells (Fig. 6b). Overall, these results conﬁrm the association between abnormal increase in Ca2+
oscillations and cell proliferation in ADPKD tubular cells, ascribing the regulatory effect of PC1
mainly to NCCE.
Figure 6. NCCE-speciﬁc inhibitors blunt the effect of the PKD1 gene silencing or PKD1 nonsense mutation on
FBS-induced increase in cell proliferation. (a) The 5 μm Gd3+, 100 nm SKF96365 and 30 μm LOE908 inhibitors
markedly inhibited the FBS-induced increase in cell proliferation of HEK293pSsiPKD1 cells (grey bars) compared to
HEK293pSUPER cells (white bars), while 1 μm Gd3+ affected to a lesser extent HEK293pSsiPKD1 cells. Cells were counted
after 48 h culture in 1% FBS, in the absence or presence of the inhibitor. Results obtained in four independent experi-
ments with different clones are shown as means ± SD. In the bar graph (on the right), the blocker effects are expressed
in terms of percentage proliferation of untreated cells. (b) Inhibitory effect of NCCE blockers on cell proliferation of
cystic kidney cell lines. Cells were treated as reported for HEK293 cells in (a). Only cystic cell proliferation was inhib-
ited by the treatment with the NCCE blockers. Bars represent mean values (± SEM) of three (for SKF96365) and two
(for LOE908) independent experiments (*P < 0.05 unpaired Student’s t-test) with cells obtained from non-cystic kidney
(white), from kidney cysts heterozygous for the Q2556X mutation (light grey) and hemizygous for the same mutation
(dark grey).Polycystin-1, Ca2+ waves and cell growth 565
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Increase in NFAT activity in HEK293pSsiPKD1 cells is associated with cell proliferation
It has been reported that oscillations are an efﬁcient way of differentially coding Ca2+ signals
and that frequency of oscillations may modulate gene transcription (Dolmetsch et al. 1998).
NFAT is a Ca2+-dependent transcription factor expressed in many cells, including those of the
kidney (Puri et al. 2004), which is regulated by frequency of Ca2+ oscillations (Tomida et al.
2003). We, therefore, investigated whether the FBS-induced oscillations observed in HEK293
PKD1-suppressed cells affected NFAT signalling. We monitored NFAT translocation to the
nucleus in HEK293pSUPER and HEK293pSsiPKD1 cells expressing a GFP-tagged NFAT2. Prior to
FBS treatment (0 min of Fig. 7a, left), NFAT-GFP was present in cytoplasmic regions of both
HEK293pSsiPKD1 and HEK293pSUPER cells, whereas its nuclear translocation following 1% FBS
treatment was clearly faster in HEK293pSsiPKD1 than in HEK293pSUPER cells. Thus, Ca2+ oscillations
induced rapid and constant NFAT nuclear translocation in HEK293pSsiPKD1. This faster activation
was also observed in PC1-mutant cystic cells (Fig. 7a, right). Moreover, HEK293 cells were
Figure 7. NFAT mediates the cell proliferation increase caused by PKD1 gene silencing and mutation. (a) The
ﬂuorescence images of representative cells transfected with NFAT-GFP construct show the distribution of the NFAT-GFP
at various time points before and after exposure to 1% FBS. The calcineurin-dependent nuclear translocation of NFAT
occurred faster in HEK293pSsiPKD1 (pSsiPKD1) and heterozygous (het) cells than in HEK293pSUPER (pS) and in normal kidney
(wt) control cells. Arrows show the marked difference in nuclear translocation between silenced and control cells.
Pictures are representative of four different experiments. (b) NFAT-dependent transcription was increased by gene silencing
of PC1. HEK293pSsiPKD1 and control cells were transfected with an NFAT-dependent luciferase reporter plasmid. Cell
extracts were collected after 20 h of 1% FBS treatment. Results of luciferase assays from a representative experiment
are shown (HEK293pSsiPKD1 clone a1 and b3, grey bars; HEK293pSUPER control cells, white bar). Results obtained are
expressed as fold activation over the luciferase units displayed by control cells. The data are the means ± SEM of ﬁve
independent experiments (**P < 0.01 paired Student’s t-test). (c) Inhibitory effect of 100 nm SKF96365 on luciferase
promoter activity in HEK293pSsiPKD1 (grey bars) and HEK293pSUPER control cells (white bars). Cells were transfected
with an NFAT-dependent luciferase reporter plasmid and results of three independent experiments are expressed as aver-
age fold increase in untreated and SKF96365-treated cells. (d) The calcineurin inhibitor Cyclosporin A (CsA) blunted
the FBS-induced increase in cell proliferation of HEK293pSsiPKD1 cells. Cells were counted after 2 days of culture in
1% FBS. CsA (100 ng/mL) was present or absent as indicated. Results obtained in a triplicate experiment are shown as
means ± SD and are representative of four independent experiments obtained from different clones.566 G. Aguiari et al.
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transiently transfected with an NFAT-promoter luciferase-reporter plasmid, and luciferase
activity was assessed after FBS treatment. Following 2 days of stimulation, ∼3.5-fold increase
in luciferase activity in HEK293pSsiPKD1 cells as compared to HEK293pSUPER cells was observed
(Fig. 7b). This suggests that gene expression is modulated by the effect of PC1 depletion on the
oscillatory pattern of Ca2+ responses and is further supported by the observation that SKF96365
treatment, which blocked HEK293pSsiPKD1 cell proliferation, also reduced the NFAT-dependent
luciferase activity (Fig. 7c).
In order to test whether the FBS-induced NFAT activation contributed to the increase in
proliferation of HEK293pSsiPKD1 cells, the cell proliferation rate was analysed in the presence of
cyclosporin A (CsA), a typical inhibitor of the Ca2+-calmodulin-dependent serine/threonine
protein phosphatase calcineurin, which dephosphorylates and activates NFAT (Puri et al. 2004).
FBS-induced increase in HEK293pSsiPKD1 cell proliferation was completely inhibited by CsA
(Fig. 7d), supporting the hypothesis of a relationship between the reduction in PC1 levels and
increase in both Ca2+ oscillations and NFAT-dependent cell proliferation in HEK293pSsiPKD1 cells.
Cytoplasmic Ca2+ levels and PKC-α α α α activity
Over all, these data suggest a model in which the impairment of PC1 signalling in PC1-deﬁcient
cells leads to elevation of serum-evoked Ca2+ oscillations, thus activating calcineurin and NFAT
signalling and leading ultimately to cell proliferation. This hypothesis is further supported by the
measurement of basal Ca2+ levels which, in the absence of serum, are higher in HEK293pSsiPKD1
than in control cells (140.78 ± 27.4 versus 85.92 ± 8.19, respectively). This is consistent with
basal Ca2+ levels observed in HEK293 cells expressing the isolated cytoplasmic carboxyl
terminus of PC1 (Manzati et al. 2005). As observed for glutamate-induced intracellular Ca2+
oscillations in astrocytes, which involve activation of conventional PKC (Codazzi et al. 2001), only
serum-induced Ca2+ oscillations lead to Ca2+ levels sufﬁcient to activate the calcium-dependent
PKC-α isoform (Fig. 8a). Serum treatment was indeed accompanied by a prominent recovery
of PKC-α-GFP ﬂuorescence in the membrane compartments of HEK293pSsiPKD1 cells, while
diffuse ﬂuorescence in control cells indicated that the kinase remains conﬁned to cytoplasm.
Because the PKC-α-speciﬁc inhibitor Ro-320432, and not the PKC-β inhibitor hispidin,
markedly reduced growth of HEK293pSsiPKD1 cell population (Fig.  8b); cell proliferation
increase was also shown to be dependent on a PKC-α pathway. As we previously observed in
HEK293 cells expressing the PC1 C-terminal tail (Manzati et al. 2005), in HEK293pSsiPKD1 cells
this increase was also accompanied by a marked reduction of the growth inhibitory protein
p27Kip1 (Fig. 8c, upper part). Consistently, p27Kip1 was similarly reduced in PKD1 Q2556X-
mutated hemizygous cystic cells (Fig. 8c, lower part). Moreover, treatment of HEK293pSsiPKD1
cells with either 5 μm Gd3+, 100 nm SKF96365 or 30 μm LOE908, which reduces cell proliferation,
led to increased p27 levels (Fig. 8d).
The present ﬁndings, therefore, provide evidence that lack of balance in PC1 levels caused by a
reduction in wild-type protein, as well as by PC1 C-tail overexpression, plays a critical role for Ca2+
signalling pathways with similar effects on gene expression and subsequently on cell cycle regulation.
DISCUSSION
Our study demonstrates for the ﬁrst time that PC1 controls Ca2+ oscillations and provides a
molecular mechanism to explain association of abnormal Ca2+ homeostasis and increased cell
proliferation in ADPKD, caused by PKD1 mutations. We have shown that either inhibition ofPolycystin-1, Ca2+ waves and cell growth 567
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PC1 expression by RNA interference in HEK293 cells or loss of PC1 expression in ADPKD
kidney cystic cells increases oscillatory activity of cytoplasmic Ca2+, evoked by low serum con-
centrations. Consistently, we have also found that expression of exogenous PC1 reduces the
frequency of serum-evoked Ca2+ oscillations not only in PC1-deﬁcient HEK293pSsiPKD1 cells,
but also in HEK293 control cells. The main conclusion of this study is therefore that PC1 is
required for negative control of Ca2+ oscillation in kidney-derived cells. The implication is that
PC1 exerts a profound inﬂuence on Ca2+ signalling by controlling Ca2+ oscillation induced by
serum, with a crucial role in cell proliferation. Cell growth studies have shown that cell proliferation
in PC1-deﬁcient HEK293 cells is inversely related to the level of PC1 expression which, in turn,
is inversely related to the Ca2+ oscillation frequency.
Figure 8. PKD1 gene silencing-dependent cell proliferation is associated to PKC-α α α α activation and reduction of
p27Kip1 in HEK293 cells. (a) The calcium-dependent membrane translocation of PKC-α occurred in serum treated
HEK293pSsiPKD1 (pSsiPKD1), but not in control cells (pS). Fluorescence images of cells expressing a PKC-α-GFP con-
struct show that the PKC-α partly translocates to the plasma membrane after 10 min exposure to 1% serum, while con-
trol cells maintain a cytoplasm diffuse staining. Arrows indicate the membrane ﬂuorescence. Pictures are representative
of three different experiments. (b) The PKC-α-speciﬁc inhibition blunted the serum-induced increase in proliferation of
HEK293pSsiPKD1. Cells were counted after 48 h culture in 1% FBS in the absence or presence of either a PKC-β-speciﬁc
(hispidin, 5 μm) or PKC-α-speciﬁc inhibitor (Ro320432, 10 μm). Results obtained in a triplicate experiment are shown
as means ± SD and are representative of three independent experiments. (c) Whole cell lysates of HEK293pSsiPKD1,
HEK293pSUPER cells (upper panel) and of non cystic (wt) and cystic PKD1 Q2556X hemizygous cells (hem) (lower
panel), were analysed by immunoblot for expression levels of p27Kip1. The levels were normalized for the expression of
actin housekeeping gene. (d) Immunoblot of total lysates of HEK293pSUPER and HEK293pSsiPKD1 cells after 24 h treat-
ment with CCE and NCCE blockers. NCCE inhibitors (100 nm SKF96365 and 30 μm LOE908) markedly increased
p27Kip1 expression only in HEK293pSsiPKD1 cells. Bar graph shows that p27Kip1 expression (grey bars) is increased of
more than twice in HEK293pSsiPKD1 cells by NCCE inhibitors, but remains unchanged in HEK293pSUPER cells. Results
have been obtained in two independent experiments and expressed as means ± SD.568 G. Aguiari et al.
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Ca2+ oscillation and cell proliferation
Intracellular Ca2+ homeostasis appears to be altered in HEK293pSsiPKD1 cells with basal Ca2+
levels higher than those of controls. Increased Ca2+ levels have already been observed in the
HEK293 cells expressing the dominant negative PC1 C-terminus (Puri et al. 2004; Manzati
et al. 2005). These results therefore indicate that loss of PC1 function may be associated with
increase in basal Ca2+ levels, which may contribute to increased proliferation of these cells. This
hypothesis is also supported by the observation that overexpression of TRPV6 slightly increases
intracellular Ca2+ levels and Ca2+-dependent proliferation of HEK293 cells (Schwarz et al.
2006). However, in primary cultures of ADPKD cystic cells reduction in basal Ca2+ levels has
been documented, imputing abnormal proliferation of cystic cells to this alteration (Yamaguchi
et al. 2006). Even though characterization of molecular lesions in primary ADPKD cultures has
not been reported, these differences in basal Ca2+ levels may be related to the different type of
cell culture. Nevertheless, in the light of these contrasting results it is difﬁcult to explain the
PKD-dependent abnormal proliferation with abnormal basal Ca2+ levels.
Interestingly, in HEK293pSsiPKD1 cells, serum treatment that increased cell proliferation,
did not produce a signiﬁcant increase in evoked Ca2+ levels (Fig. 2a), but rather a clear change
(2-fold statistically signiﬁcant increase) in frequency of FBS-induced Ca2+ oscillations. Notably,
frequency of Ca2+ oscillation is also increased in cystic cells either heterozygous or hemizygous
for the Q2556X PKD1. Because both cystic cell lines show increased FBS-evoked Ca2+ oscillations,
these may be a cause of aberrant proliferation in these cells as well as in HEK293pSsiPKD1 cells.
It must, however, be considered that the present study was performed in immortalized cells.
Although these are derived from normal and cyst-lining epithelia and maintain many
features of tubule of origin, immortalized cells are poorly differentiated and polarized, particularly
when cultured under subconﬂuent conditions such as those used for a proliferation study.
Therefore, the precise role of abnormal Ca2+ oscillations on cyst formation and cell population
growth in the kidney remains to be ascertained.
The ﬁnding that HEK293 cells expressing mouse PC1 showed reductions in both Ca2+
oscillation and cell proliferation, provides evidence for the role of Ca2+ oscillations in the PC1-
dependent control of cell proliferation. In the light of these observations therefore growth
suppression activity of PC1 may be explained by its inhibitory action on Ca2+ oscillations as was
observed in both normal and HEK293pSsiPKD1 cells exogenously expressing the mouse PC1.
Ca2+ channel activity and cell proliferation
Ca2+ entry that supports [Ca2+]i cycling, predominantly occurs through store-operated or a CCE
pathway (Bird & Putney 2005). Nevertheless, in many cell types, including HEK293 cells, extra-
cellular Ca2+ entry and Ca2+ oscillations also result from NCCE, whose activation is independent
of store depletion (Mignen et al. 2001).
Non-capacitative Ca2+ entry activity appears to be crucial for HEK293pSsiPKD1 cell proliferation.
Ca2+ oscillations in HEK293pSsiPKD1 cells are insensitive to 1 μm Gd3+, but markedly inhibited by
the NCCE blocker, which also inhibited cell proliferation. Moreover, in the absence of external
Ca2+, no difference was observed in 1% evoked Ca2+ oscillations between HEK293pSsiPKD1 and
HEK293pSUPER control cells (3.34 ± 0.31 versus 2.58 ± 0.9 oscillations in 15 min/cell, respec-
tively), consistently with a role of NCCE activity on the oscillation increase. Therefore, the PC1
loss leads to deregulation of the NCCE pathway, strongly associating increased Ca2+ oscillations
and proliferation to abnormal activity of NCCE channels. Consistently, both SKF96365 and
LOE908 are able to reduce proliferation in PKD1-mutated heterozygous and hemizygous cystic
cells, but not wild-type kidney tubule cells. Ca2+ inﬂux through NCCE channels is therefore
necessary for the increased [Ca2+]i oscillatory response and cell proliferation in PC1-deﬁcient cells.Polycystin-1, Ca2+ waves and cell growth 569
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On the basis of these considerations, we hypothesize that PC1 controls an as yet uninvestigated
activity of NCCE channels. In HEK293 cells, NCCE has been shown to be associated to the
activity of the arachidonate-regulated Ca2+ channel (ARC channel) (Mignen et al. 2003a), but
because we have observed that calcineurin activity is required for the FBS-induced proliferation
increase in HEK293pSsiPKD1 cells (Fig. 7d), and because ARC channels are turned off by
calcineurin activation (Mignen et al. 2003b), these channels do not seem to be the target of the
PC1 control. On the other hand, an arachidonate-activated NCCE channel activity, which displays
biophysical properties different from the ARC channels of HEK293 cells, has been reported in
endothelial cells (Fiorio Pla & Munaron 2001). Interestingly, this NCCE activity is required for
the promotion of cell proliferation activated by peptidic growth factors like the basic ﬁbroblast
growth factor (Fiorio Pla & Munaron 2001). This NCCE activity is also involved in peripheral
and localized Ca2+ events, probably leading to the involvement of differential patterns of Ca2+-
dependent proteins and genes (Tomatis et al. 2007), including calcineurin and PKC pathways,
abnormally activated in HEK293pSsiPKD1 cells. This activity may lead, in addition to increased
cell proliferation, to the abnormal polarity, migration and apoptosis typically observed in
ADPKD cystic cells (Ong & Harris 2005).
Ca2+ oscillations and signalling
The results of our studies suggest that a loss of PC1 in HEK293pSsiPKD1 cells promotes a
serum-induced proliferation increase by inducing Ca2+ entry and subsequent activation of the
calcineurin/NFAT pathway. As reported in other cell types (Lipskaia & Lompre 2004), NFAT
activation in HEK293pSsiPKD1 cells promotes cell cycle progression in association with a reduction
in the activity of cyclin kinase inhibitors. Consistently, cyclosporin A treatment, which, by inhibiting
calcineurin, inhibits NFAT dephosphorylation and its nuclear translocation (Hogan et al. 2003),
blocks the PC1-dependent increase in proliferation (Fig. 7d). Here, we also show that once
NCCE-mediated Ca2+ entry is blocked by SKF96365 treatment in HEK293pSsiPKD1 cells, NFAT
activation is markedly reduced. Thus, as previously demonstrated in other cell types (Dolmetsch
et al. 1998; Tomida et al. 2003), activation of NFAT in HEK293pSsiPKD1 appears to be linked to
increase in Ca2+ oscillation, possibly accompanied by the release of Ca2+ from intracellular
stores and activation of store-operated Ca2+ entry, as proposed in cells expressing the PC1 C-
terminus (Puri et al. 2004). Because this peptide appears to act as a dominant negative (Manzati
et al. 2005; Xu et al. 2007), NFAT activation in these cells is consistent with that found in
HEKpSsiPKD1 cells. HEK293pSsiPKD1 cell proliferation requires PKC-α activation and p27 down-
regulation (see Fig. 8), as in cells expressing the PC1 C-terminus that show reduced levels of
both p27Kip and p21Waf associated to increased cell proliferation (Manzati et al. 2005). This
observation is consistent with previous ﬁndings showing that exogenous expression of full-
length PC1 in kidney cells induces cell cycle arrest in G0/G1 by up-regulating p21Waf expression
through the JAK-STAT pathway (Bhunia et al. 2002). It has also been reported that calcineurin
and NFAT activity is required in keratinocytes for the expression of p21 and p27, which
contribute to growth arrest of these cells (Santini et al. 2001). This supports the postulated
cross-talk between calcineurin, p21 and p27. In HEK293pSsiPKD1, this cross-talk may either be
misfunctional or p27 gene down-regulation may result by one or more different Ca2+-dependent
signalling pathways activated by PC1 depletion (see Fig. 8).
Furthermore, the association between PKC-α membrane translocation and Ca2+ oscillation
is consistent with the activation of PKC by glutamate-induced Ca2+ waves in astrocytes (Codazzi
et al. 2001).
Because NFAT nuclear translocation occurs in HEK293pSsiPKD1 and control cells only after
serum treatment, the role of basal Ca2+ again appears to be irrelevant in the proliferation increase of570 G. Aguiari et al.
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PC1-deﬁcient cells, while the role of Ca2+ oscillations appears to be crucial. These results
provide new insight into the molecular and physiological mechanism of Ca2+ oscillations in
PKD1-like kidney cells and in promoting NFAT-dependent kidney cell proliferation.
In summary, our results establish that the molecular suppression of endogenous PC1 in
HEK293 cells and PKD1 cystic cells leads to abnormal Ca2+ oscillations and has a profound
inﬂuence on Ca2+ signalling and cell proliferation, as illustrated in Fig. 9. At present, it is impossible
to say how many steps may lie between PC1 and the NCCE channel. Because PC1 has been
implicated in gene expression control by activating a variety of transcription factors including
the NFAT investigated here, NCCE modulation may result from changes in gene expression, or
in post-translational modiﬁcation (Li et al. 2005). Moreover, either a direct or indirect interaction
between PC1 and NCCE channel may exist. PC1 may, in fact, constitute Ca2+-permeable
channel activities either by interacting with PC2 in the PC1/PC2 receptor-ion channel (Hanaoka
et al. 2000), or independently of PC2 (Babich et al. 2004).
In conclusion, our ﬁndings suggest that PC1 may function as a controller of Ca2+ release in
response to extracellular stimuli also through the NCCE pathway, thus regulating the Ca2+-mediated
signal transduction involved in cell proliferation through the NFAT pathway. Moreover, because
NCCE channel blockers may reduce the PC1 suppression-dependent [Ca2+]i oscillation as well
Figure 9. A hypothetical model illustrating the role of PC1 on the agonist-evoked NCCE channel activity and
effects of Ca2+ oscillations (Ca2+Os) on NFAT pathway and cell proliferation. In HEK293pSUPER and tubular kidney
control cells, PC1 negatively modulates NCCE activity through a still undeﬁned direct or indirect mechanism (dotted
bar); Ca2+ oscillations are dependent on both CCE and NCCE activities as shown by comparable inhibitory effects of
1 μm Gd3+ and SKF96365 on Ca2+ oscillations and cell proliferation (Figs 5 and 6). Loss of PC1 function causes an
increase in NCCE channel activity and in Ca2+ oscillations thus leading to an increase in Ca2+-dependent NFAT activation
and cell proliferation.Polycystin-1, Ca2+ waves and cell growth 571
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as cell proliferation, these channels could be potential therapeutic targets for treatment of the
abnormalities observed in cystic cells.
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